GSK (GSK) Other Long-Term Liabilities

: $9,616 Mil (As of Dec. 2023)

View and export this data going back to 1987. Start your Free Trial

GSK's other long-term liabilities for the quarter that ended in Dec. 2023 was $9,616 Mil.

GSK's quarterly other long-term liabilities increased from Jun. 2023 ($9,222 Mil) to Sep. 2023 ($9,384 Mil) and increased from Sep. 2023 ($9,384 Mil) to Dec. 2023 ($9,616 Mil).

GSK's annual other long-term liabilities declined from Dec. 2021 ($13,838 Mil) to Dec. 2022 ($9,289 Mil) but then increased from Dec. 2022 ($9,289 Mil) to Dec. 2023 ($9,616 Mil).

GSK Other Long-Term Liabilities Historical Data

The historical data trend for GSK's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GSK Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

GSK Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Long-Term Liabilities																-	-	-	-	-

GSK Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

GSK Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of GSK's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

GSK (GSK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (NYSE:GSK) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

GLAXF:USA GSK N:Mexico GSKl:UK GSK:UK GS71:Germany GS70:Germany GS71:Germany GS70:Germany GS71:Germany G1SK34:Brazil GSK:Argentina

Address

980 Great West Road, Brentford, Middlesex, GBR, TW8 9GS

Website

https://www.gsk.com

In the pharmaceutical industry, GSK ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.